MBIO Mustang Bio, Inc.
Healthcare$0.62-1.60%ClosedMarket Cap: $4.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.49
P/S
0.00
EV/EBITDA
3.72
DCF Value
$2.93
FCF Yield
-101.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-35.4%
ROA
-16.4%
ROIC
-37.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.1M | $-955.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-670.0K | $-538.0K | $— | — |
| FY null | $0.00 | -Infinity% | $-2.4M | $-1.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-624.0K | $-468.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-885.0K | $-762.0K | $— | — |
| Q1 null | $0.00 | -Infinity% | $-253.0K | $-153.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-1.0M | $-952.0K | $— | — |
| FY null | $0.00 | NaN% | $-16.2M | $-15.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.5M | $-1.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.5M | $-8.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-5.2M | $-5.2M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-8.7M | $-8.6M | $-0.93 | — |